Acute hepatitis F5: Acute hepatitis with ear infection, nephritis, gastritis, fever, joint pain or low energy with sluggish feeling.
1. Hepatitis: 72 acute jaundice hepatitis patients took F5 or its modification from 17 to 49 days and 64 cured (88.88 percent), 7 significantly improved (9.72 percent) and only one did not improve.
2. Suppurative ear infection: 110 patients age from 5 to 67 years old taking F5 formula or its modifications for three weeks. 66 were cured (60.0%) with no suppurative discharge, no recurrence in three years and hearing increased to 10 to 15 db. 17 significantly improved (15.45%), with basically no discharge, and hearing improved by 20 to 30 db. Only 8 patients did not improve (7.27%).
3. Gastritis: 300 acute gastritis patients took F5 or its modification found 281 were cured in eight days and the rest 19 were also significantly improved.
4. Nephritis: 160 patients of various nephritis were treated with F5 for a month. 128 were cured (80 percent), 18 significantly improved (11.25 percent), 8 improved (5 percent) and six did not.
5. Fever: 608 chronic fever patients (up to 106 F) treated with F5 or its modification for up to a month. 444 were cured (73.02 percent), 147 improved (24.17 percent) and 17 did not respond to the treatment (2.79 percent).
6 Joint pains: 97 patients with joint problems that are more severe in the cold, humid weather with swollen joint and numbness. All patients have histories from one month to three years took F5 or its modification for up to 8 weeks found 57 cured (58.76 percent), 20 significantly improved (20.61 percent), 13 improved (13.40percent) and seven did not improve.
Toxicity and side effects: There is no known side effect or toxicity reported on F5.
